These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15990130)

  • 21. Toxicogenomics--a new systems toxicology approach to understanding of gene-environment interactions.
    Olden K
    Ann N Y Acad Sci; 2006 Sep; 1076():703-6. PubMed ID: 17119247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P; Sasaki J
    Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ecotoxicogenomics: linkages between exposure and effects in assessing risks of aquatic contaminants to fish.
    Miracle AL; Ankley GT
    Reprod Toxicol; 2005; 19(3):321-6. PubMed ID: 15686867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of emerging technologies in toxicology and safety assessment.
    Reynolds VL
    Int J Toxicol; 2005; 24(3):135-7. PubMed ID: 16040564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormesis [biological effects of low-level exposure (B.E.L.L.E.)] and dermatology.
    Thong HY; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):329-41. PubMed ID: 18058307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systems biology and mode of action based risk assessment.
    Edwards SW; Preston RJ
    Toxicol Sci; 2008 Dec; 106(2):312-8. PubMed ID: 18791183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Priority setting for risk assessment--the benefit of human experience.
    Alonzo C; Laborde A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):692-6. PubMed ID: 16153990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of toxicogenomics to genetic toxicology risk assessment.
    Thybaud V; Le Fevre AC; Boitier E
    Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of statistics in toxicogenomics.
    Elashoff M
    Methods Mol Biol; 2008; 460():69-87. PubMed ID: 18449483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling exposure to persistent chemicals in hazard and risk assessment.
    Cowan-Ellsberry CE; McLachlan MS; Arnot JA; Macleod M; McKone TE; Wania F
    Integr Environ Assess Manag; 2009 Oct; 5(4):662-79. PubMed ID: 19552503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints.
    Preston RJ
    Environ Mol Mutagen; 2005; 45(2-3):214-21. PubMed ID: 15645441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rational approach to risk assessment requires the use of biological information: an analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counselors.
    Goodman JI
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):51-9. PubMed ID: 8159815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of regulatory toxicology: impact of the biotechnology revolution.
    MacGregor JT
    Toxicol Sci; 2003 Oct; 75(2):236-48. PubMed ID: 12883082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptomics analysis of interactive effects of benzene, trichloroethylene and methyl mercury within binary and ternary mixtures on the liver and kidney following subchronic exposure in the rat.
    Hendriksen PJ; Freidig AP; Jonker D; Thissen U; Bogaards JJ; Mumtaz MM; Groten JP; Stierum RH
    Toxicol Appl Pharmacol; 2007 Dec; 225(2):171-88. PubMed ID: 17905399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.